Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.2 (
NQO1
)
6,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The oxidoreductase
NQO1
plays a prominent role in maintaining the cellular homeostasis.
NQO1
is mainly a cytosolic enzyme which catalyzes the metabolism of quinones and is present in almost all tissue types providing protection against different stresses including xenobiotics, oxidants, UV light, and ionizing radiation. This enzyme is overexpressed in many cancerous tissues and its function in carcinogenesis remains unclear. Due to the relative lack of information on the role of
NQO1
in melanoma pathogenesis, we attempted to determine the expression and basic function of
NQO1
in melanoma cell proliferation. We found that
NQO1
is overexpressed in most melanoma cell lines with respect to melanocytes. Furthermore, the expression of this oxidoreductase significantly induces cell cycle progression by upregulating the expression of cyclins A2, B1 and D1, leading to the proliferation of melanoma cells. Our results also indicate that
NQO1
is an upstream regulator of NF-kappaB p50, a factor linked to melanoma progression and poor patient prognosis. Interestingly, we found that
NQO1
stabilizes the transactivator
BCL3
, which in turn upregulates NF-kappaB p50. More importantly, our results also indicate that NF-kappaB p50 correlates with the expression of
NQO1
and mediates its role in the proliferation of melanoma cells.
...
PMID:The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells. 2022 54